# Enliven Therapeutics, Inc.: Form 8-K, filed Aug 13, 2024

- Company: [Enliven Therapeutics, Inc.](/companies/elvn.md) (CIK 1672619)
- Form: 8-K
- Filed: 2024-08-13
- Accepted by EDGAR: Aug 13, 2024, 16:10 ET
- Period: 2024-08-13
- Accession: 0000950170-24-096204
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1672619/000095017024096204/elvn-20240813.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1672619/000095017024096204/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1672619/000095017024096204/elvn-20240813.htm

Filed Aug 13, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-096204. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.